CRL vs ECL · rev $4.05B vs P/E 35, rev $4.01B
Charles River Laboratories (CRL) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CRL currently screens at market cap $7.78B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CRL and ECL stock pages for the full models.
Not investment advice.